ATE218345T1 - Arzneimittel gegen spinocerebellare degeneration - Google Patents

Arzneimittel gegen spinocerebellare degeneration

Info

Publication number
ATE218345T1
ATE218345T1 AT95927966T AT95927966T ATE218345T1 AT E218345 T1 ATE218345 T1 AT E218345T1 AT 95927966 T AT95927966 T AT 95927966T AT 95927966 T AT95927966 T AT 95927966T AT E218345 T1 ATE218345 T1 AT E218345T1
Authority
AT
Austria
Prior art keywords
represent
spinocerebellar degeneration
drugs
ococh3
hydrogen
Prior art date
Application number
AT95927966T
Other languages
English (en)
Inventor
Tetsuo Sakai
Yasunobu Antoku
Toyojiro Matsuishi
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE218345T1 publication Critical patent/ATE218345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
AT95927966T 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration ATE218345T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18468294 1994-08-05
PCT/JP1995/001550 WO1996003989A1 (fr) 1994-08-05 1995-08-04 Remede contre la degenerescence spino-cerebelleuse

Publications (1)

Publication Number Publication Date
ATE218345T1 true ATE218345T1 (de) 2002-06-15

Family

ID=16157531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927966T ATE218345T1 (de) 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration

Country Status (6)

Country Link
US (1) US5753656A (de)
EP (1) EP0722731B1 (de)
AT (1) ATE218345T1 (de)
DE (1) DE69526918T2 (de)
ES (1) ES2177654T3 (de)
WO (1) WO1996003989A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418097A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
DE69733308D1 (de) * 1996-07-31 2005-06-23 Cmic Co Aktivsauerstoffaufnehmer enthaltende pterinderivate
KR100650962B1 (ko) † 1996-08-30 2007-07-18 다이이치 아스비오파마 가부시키가이샤 질소산화물합성효소(nos)의기능저하에의해유발되는질환의예방또는치료제
JP4306825B2 (ja) 1998-02-27 2009-08-05 アスビオファーマ株式会社 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7167844B1 (en) 1999-12-22 2007-01-23 Accenture Llp Electronic menu document creator in a virtual financial environment
US7610233B1 (en) 1999-12-22 2009-10-27 Accenture, Llp System, method and article of manufacture for initiation of bidding in a virtual trade financial environment
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
BR0308556A (pt) * 2002-03-21 2005-05-03 Martin C Hinnz Tecnologia de otimização do segmento de sistema de serotonina e de catecolaminas
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP1696877A4 (de) * 2003-11-13 2010-06-09 Gen Hospital Corp Verfahren zur schmerzbehandlung
EP1708690B1 (de) 2003-11-17 2016-07-20 BioMarin Pharmaceutical Inc. Behandlung von phenylketonurie mit bh4
US20080207624A1 (en) * 2004-05-11 2008-08-28 Osamu Sugita Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
CA2581814C (en) 2004-11-17 2015-10-13 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
WO2006063215A2 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
WO2007067570A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
JP2010515747A (ja) * 2007-01-12 2010-05-13 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンプロドラッグ
US20100009997A1 (en) * 2007-01-12 2010-01-14 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug
PT2139485E (pt) 2007-04-11 2013-01-16 Biomarin Pharm Inc Métodos de administração da tetra-hidrobiopterina, composições associadas e métodos de medição
BRPI0821970A2 (pt) 2008-01-03 2015-06-23 Biomarin Pharm Inc Análogos de pterina para tratamento de condição responsiva a bh4
EP2562176B1 (de) 2010-04-22 2018-08-15 Nihon University Medizinisches mittel und getränk/nahrungsmittel zur verhinderung zerebraler dysfunktion
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
AU2018277981B2 (en) * 2017-06-02 2021-04-08 Fujifilm Toyama Chemical Co., Ltd. Agent for preventing or treating spinocerebellar ataxia
MX2020012978A (es) * 2018-05-30 2021-04-28 Ptc Therapeutics Mp Inc Sales de sepiapterina farmacéuticamente aceptables.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
ZA836957B (en) * 1982-09-20 1985-04-24 Wellcome Found Neurologically active chemical compounds
JPS61277618A (ja) 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
EP0592673B1 (de) * 1991-11-16 1999-05-26 Suntory Limited Rezeptor für 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin

Also Published As

Publication number Publication date
DE69526918T2 (de) 2002-12-19
US5753656A (en) 1998-05-19
EP0722731A4 (de) 1998-03-04
DE69526918D1 (de) 2002-07-11
EP0722731B1 (de) 2002-06-05
ES2177654T3 (es) 2002-12-16
WO1996003989A1 (fr) 1996-02-15
EP0722731A1 (de) 1996-07-24

Similar Documents

Publication Publication Date Title
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
EP1036794A4 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
DE69831868D1 (en) Antithrombosemittel
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
WO2001072728A3 (en) Novel piperazine derivatives
AU7278500A (en) Fungicides
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
PT928788E (pt) Compostos farmaceuticamente activos
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
CA2336412A1 (en) Medicament for treatment of diabetes
ES2072223B1 (es) Liposomas encapsulando doxorubicina.
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
EP0754683A4 (de) Etherverbindungen, ihre verwendung und zwischenprodukte zu ihrer herstellung
WO2000046210A3 (en) New process for preparing pesticidal intermediates
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
EP1026162A4 (de) Antirheumatika
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
EP0816366A4 (de) Imidazothiazolverbindungen
MX9206930A (es) Nuevos compuestos
AU4732096A (en) Remedy for pulmonary heart
EP0358091A3 (de) 2-Zyklohexylpropanal-Derivate und diese enthaltende Parfümeriezusammenstellungen
EP1136488A4 (de) Sf2809-i, ii, iii. vi, v und vi-verbindungen mit chymase-inhibierender wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties